- BBS Pharmaceuticals Contact
- contact@bbspharmaceuticals.com
BBS Pharmaceuticals News
[display-posts include_excerpt=”true” excerpt_length=”20″ image_size=”thumbnail” wrapper=”div” wrapper_class=”display-posts-listing image-left”]
July 18, 2020
BBS Pharmaceuticals, a licensed cultivatotor and manufacturer of medicinal cannabis products would like toto congratulate Minister David Littleproud and the Australian Parliament in passing the Export […]
June 11, 2020
It has been a busy and incredibly productive start of the week here at BBS as we are entering the second half of the year. This […]
April 30, 2020
Australia has published a framework for new CBD regulations as it considers relaxing its narcotics scheduling of cannabidiol toto make it available over the counter in […]
April 23, 2020
These are challenging times as the world responds toto the coronavirus outbreak and sets a path toto recovery. First off, our hearts go out toto anyone […]
April 14, 2020
As various phases of legalisation come intoto effect in different parts of Australia, the country’s cannabis market is expected toto break through the barrier of US$1.5 […]
March 27, 2020
The Australian Senate Committee has revealed their recommendations from the inquiry ‘Current barriers toto patient access toto medicinal cannabis in Australia’. In its 118-page long document, […]
March 12, 2020
In the coming months, the TGA will expand the number of quality audits of medicinal cannabis products imported or supplied under the Special Access Scheme (SAS) […]
February 28, 2020
A scientific study conducted by Professor Poulas Konstantinos and his team from the Department of Pharmacy at the University of Patras in Greece, and in collaboration […]
February 20, 2020
Even on a good day, eight-year-old Sophie Martin has hundreds of seizures. When she has a severe seizure, she turns blue and cannot breathe. She has […]